期刊文献+

裸鼠异种移植急性T淋巴细胞白血病模型的建立 被引量:1

Stablishment of acute T-lymphocyte leukemia model by xenotransplantation from nude mice
下载PDF
导出
摘要 目的比较尾静脉注射和皮下注射人Jurkat细胞建立异种移植急性T淋巴细胞白血病模型的优缺点。方法雌性BALB/c裸鼠随机分为正常组、尾静脉移植组和皮下移植组。除正常组外,其余裸鼠造模前连续2 d给予环磷酰胺(2 mg/只),尾静脉移植组连续2 d尾静脉接种5×106个Jurkat细胞,皮下移植组连续2 d皮下接种5×106个Jurkat细胞,正常组裸鼠尾静脉注射相同体积PBS缓冲液。观察并记录裸鼠体质量、弓背以及精神状态。第7天和第14天通过流式细胞术检测Jurkat细胞在裸鼠外周血中浸润情况。第28天待尾静脉移植组和皮下移植组裸鼠出现衰竭体征濒临死亡时处死裸鼠,记录裸鼠体质量,瑞氏-吉姆萨染色检测外周血和骨髓中Jurkat细胞的浸润情况,流式细胞术检测脾脏和骨髓中Jurkat细胞的百分比,HE染色、免疫组化法检测肝脏和脾脏中浸润的Jurkat细胞表达,ELISA检测血清中Jurkat细胞分泌IL-2水平。结果与正常组相比,尾静脉移植组和皮下移植组裸鼠均逐渐出现体质量下降、弓背、食欲减退等表现,肝脏、脾脏及骨髓中均有人Jurkat细胞表达。尾静脉移植组成模率73%,皮下移植组成模率40%。结论尾静脉注射和皮下注射异种移植Jurkat细胞两种方法均可成功建立急性T淋巴细胞白血病动物模型,尾静脉注射移植效果更佳。 Objective To compare the advantages and disadvantages between caudal vein injection and subcutaneous injection of human Jurkat cells in the establishment of xenograft acute T lymphocytic leukemia model.Methods Female BALB/c nude mice were randomly divided into normal group,tail vein transplantation group and subcutaneous transplantation group.The tail vein transplantation group and subcutaneous transplantation groups were given cyclophosphamide for 2 consecutive days before modeling.5×106 Jurkat cells were inoculated via tail vein in tail vein transplantation group for 2 consecutive days,and 5×106 Jurkat cells were subcutaneously injected into subcutaneous transplantation group for 2 consecutive days.The same volume of phosphate buffer saline was injected into the normal group by tail vein.The body weight,bow back and mental state of nude mice were observed and recorded.The percentages of Jurkat cells in peripheral blood were monitored by flow cytometry on the 7th and 14th day.On the 28th day,the mice appeared signs of failure and were close to death,and they were put to death.At the same time,the body weight was recorded.Wright′s stain was used to detect the infiltration of Jurkat cells in peripheral blood and bone marrow,spleen and bone marrow of the Jurkat invasion was detected by flow cytometry.Pathology of liver and spleen was also observed by HE staining,and infiltration of Jurkat cells was observed by immunohistochemistry.The level of IL-2 secreted by Jurkat cells in serum was detected by ELISA.Results Compared with the normal group,the tail vein transplantation group and subcutaneous transplantation groups nude mice gradually showed weight loss,bow back and loss of appetite,and Jurkat cells were expressed in the liver,spleen and bone marrow of the mice in each group.The success rate of tail vein transplantation group was 73%,and the success rate of subcutaneous transplantation group was 40%.Conclusion Both tail vein injection and subcutaneous injection of human Jurkat cells can successfully establish
作者 张爱君 潘文文 胡晓曦 吴育晶 魏伟 Zhang Aijun;Pan Wenwen;Hu Xiaoxi(Institute of Clinical Pharmacology,Anhui Medical University,Key Laboratory of Anti-inflammatory and Immune Medicine,Ministry of Education,Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine,Hefei 230032)
出处 《安徽医科大学学报》 CAS 北大核心 2021年第6期908-914,共7页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81973332、81603121)。
关键词 急性T淋巴细胞白血病细胞 BALB/C裸鼠 异种移植 动物模型 尾静脉注射 皮下注射 acute T-lymphoblastic leukemia cell BALB/c nude mice xenograft animal model tail vein injection subcutaneous injection
  • 相关文献

参考文献2

二级参考文献30

  • 1Bosma MJ,Carroll AM.The SCID mouse mutant: definition, characterization, and potential uses. Annual Review of Immunology . 1991 被引量:1
  • 2Vogelstein B,Kinzler KW.Cancer genes and the pathways they control. Nature Medicine . 2004 被引量:1
  • 3Boucheix C,David B,Sebban C,et al.Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87).French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood . 1994 被引量:1
  • 4Schultz LD,Schweitzer PA,Christianson SW,et al.Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. Journal of Immunology . 1995 被引量:1
  • 5Wang J C Y,Lapidot T,Cashman J D,et al.High level engraftment of NOD SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood . 1998 被引量:1
  • 6Li S,Ilaria RL Jr,Million RP,et al.The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. The Journal of Experimental Medicine . 1999 被引量:1
  • 7Plasilova M,Zivny J,Jelinek J,et al.TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia . 2002 被引量:1
  • 8Annino L,VegnaML,Camera A,et al.Treatment of adult acute lymphoblastic leukem ia (ALL): long-term follow-up of the GIMEMA ALL-0288 random ized study. Blood . 2002 被引量:1
  • 9LD Shultz,F Ishikawa,DL Greiner.Humanized mice in translational biomedical research. Nature Reviews Immunology . 2007 被引量:1
  • 10Cesano A,Hoxie JA,Lange B,et al.The severe combined immunodeficient(SCID) mouse as a model for human myeloid leukemias. Oncegene . 1992 被引量:1

共引文献7

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部